Cerebras Systems (CBRS) launched its initial public offering on May 14, 2026, at a price of $350 per share. In the weeks since, shares have retreated 23.54%, settling near $233 in Tuesday’s trading session.
Yet Wall Street research desks are responding with enthusiastic endorsements.
Atif Malik from Citi opened coverage with a Buy grade and established the most bullish Street target at $340. This forecast implies approximately 46% appreciation from present trading levels.
Craig-Hallum subsequently launched coverage with its own Buy recommendation and a $325 objective. The research shop emphasized Cerebras’ proprietary wafer-scale computing architecture, arguing it outperforms competing AI inference technologies in speed metrics.
Cerebras engineered the industry’s inaugural wafer-scale processing technology — a semiconductor that occupies an entire silicon wafer instead of being divided into separate chips.
Malik forecasts Cerebras will command between 40% and 50% of the rapid inference segment. Applied to his $130 billion total addressable market projection, this translates to potential revenue ranging from $52 billion to $65 billion.
Craig-Hallum presents an even more expansive view — anticipating the AI inference sector will exceed $250 billion before 2030 arrives.
Both OpenAI and Amazon designated Cerebras as their inference provider within the past six months. According to Craig-Hallum, these agreements signal to the broader market that Cerebras represents a credible substitute to established solutions.
The research firm emphasized that processing speed has emerged as a critical competitive factor in artificial intelligence — referencing recent model releases that impose premium pricing explicitly for accelerated response capabilities.
Cerebras generated $510 million in trailing twelve-month revenue, reflecting 76% year-over-year expansion. The enterprise has already achieved positive earnings.
This combination is uncommon among recently public technology companies.
Numerous additional research firms launched coverage alongside Citi and Craig-Hallum.
Needham assigned CBRS a Buy grade with a $300 objective, emphasizing its exclusive role as the only provider of Wafer-Scale Engines. Rosenblatt similarly rated it Buy at $300, spotlighting performance metrics from its third-generation platform.
Wedbush initiated with an Outperform designation and $270 target. Mizuho mirrored Wedbush’s Outperform assessment while establishing a $300 objective. Barclays entered with an Overweight stance at $280.
Among all 10 research firms covering the stock, the consensus rating is Strong Buy. The mean price objective stands at $294.
Tuesday’s trading volume registered approximately 1.75 million shares, significantly beneath the stock’s typical daily average of roughly 25 million.
Barclays particularly underscored the OpenAI and Amazon partnerships as transformational developments for Cerebras within the AI semiconductor landscape.
The post Cerebras Systems (CBRS) Stock Falls 23% Post-IPO as Analysts Project 46% Rally Ahead appeared first on Blockonomi.
